Direct Biologics, LLC

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• MAMark AdamsExecutive Officer
• ABAline BetancourtExecutive Officer
• GFGordon FellerDirector · Executive Officer
• ALAmy LightnerExecutive Officer
• JMJeffrey MimsExecutive Officer
• TMTimothy MoseleyExecutive Officer
• MRMatthew RogersDirector · Executive Officer
• ESEmil Schmidt IVExecutive Officer
• JVJohn VacalisExecutive Officer

• 18 Jun 2026Compositions And Methods For Treating Acute Respiratory Distress Syndromeapplication
• 31 Mar 2026Methods And Compositions For Treating Inflammatory Conditions Associated With Infectious Diseasegranted
• 10 Mar 2026Method For Treating Osteoarthritis With Mesenchymal Stem Cell Exosomesgranted
• 10 Mar 2026Methods And Compositions For Treating Inflammatory Conditions Associated With Infectious Diseasegranted
• 23 Dec 2025Treatment Of Fistula With Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesiclesgranted
• 18 Dec 2025Method For Treating Osteoarthritis With Mesenchymal Stem Cell Exosomesapplication
• 28 Oct 2025A Mesenchymal Stem Cell (msc) Growgh Factor And Extracellular Vesicle Preparation In Frozen Of Powdered Form And Methods Of Usegranted
• 12 Jun 2025Preparations Comprising Mesenchymal Stem Cells And Cannabinoids And Methods Of Their Useapplication
• 04 Feb 2025Preparations Comprising Mesenchymal Stem Cells And Cannabinoids And Methods Of Their Usegranted
• 21 Dec 2023Oral Delivery Of Therapeutic Mammalian Cellsapplication
• 05 Oct 2023Rna Comprising Secretomes And Methods Of Their Useapplication
• 30 Jun 2022Method For The Treatment Of Periodontal Disease Using Characterized Mesenchymal Stem Cell Growth Factors And Exosomesapplication

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.